57 related articles for article (PubMed ID: 17180085)
1. Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).
Gilbert MS; Rupnow BA; Ramirez DA; Trisler KD; Knox SJ
Cell Death Differ; 1996 Apr; 3(2):215-22. PubMed ID: 17180085
[TBL] [Abstract][Full Text] [Related]
2. Influence of Bcl-2 overexpression on Na+/K(+)-ATPase pump activity: correlation with radiation-induced programmed cell death.
Gilbert M; Knox S
J Cell Physiol; 1997 Jun; 171(3):299-304. PubMed ID: 9180899
[TBL] [Abstract][Full Text] [Related]
3. Association of BCL-2 with membrane hyperpolarization and radioresistance.
Gilbert MS; Saad AH; Rupnow BA; Knox SJ
J Cell Physiol; 1996 Jul; 168(1):114-22. PubMed ID: 8647905
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic defense of bcl-2 gene against hydroperoxide-induced cytotoxicity together with suppressed lipid peroxidation, enhanced ascorbate uptake, and upregulated Bcl-2 protein.
Saitoh Y; Ouchida R; Kayasuga A; Miwa N
J Cell Biochem; 2003 May; 89(2):321-34. PubMed ID: 12704795
[TBL] [Abstract][Full Text] [Related]
5. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
[TBL] [Abstract][Full Text] [Related]
6. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
7. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
Papadopoulou MV; Ji M; Khan SH; Bloomer WD
Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death and Bcl-2 protection in very low oxygen.
Jacobson MD; Raff MC
Nature; 1995 Apr; 374(6525):814-6. PubMed ID: 7536895
[TBL] [Abstract][Full Text] [Related]
10. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
Keohane A; Godden J; Stratford IJ; Adams GE
Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
[TBL] [Abstract][Full Text] [Related]
11. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
Raffo AJ; Perlman H; Chen MW; Day ML; Streitman JS; Buttyan R
Cancer Res; 1995 Oct; 55(19):4438-45. PubMed ID: 7671257
[TBL] [Abstract][Full Text] [Related]
14. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
16. The effect of pH on the aerobic and hypoxic cytotoxicity of SR4233 in HT-29 cells.
Skarsgard LD; Skwarchuk MW; Vinczan A; Chaplin DJ
Br J Cancer; 1993 Oct; 68(4):681-3. PubMed ID: 8398693
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells.
Chiao C; Carothers AM; Grunberger D; Solomon G; Preston GA; Barrett JC
Cancer Res; 1995 Aug; 55(16):3576-83. PubMed ID: 7543016
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
[TBL] [Abstract][Full Text] [Related]
19. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-kappaB (RelA)-selective targeting.
Haddad JJ; Land SC
Biochem Biophys Res Commun; 2000 Apr; 271(1):257-67. PubMed ID: 10777712
[TBL] [Abstract][Full Text] [Related]
20. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
Koch CJ
Cancer Res; 1993 Sep; 53(17):3992-7. PubMed ID: 8358728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
